Cardiothoracic & vascular anesthesia

Impact of Intraoperative Hyperoxia Versus Normoxia on Mortality and Organ Injury in Cardiac Surgery: A Systematic Review and Meta-analysis of Randomized Clinical Trials

J Cardiothorac Vasc AnesthPublished Systematic review and meta-analysis of randomised trials

Authors' conclusion

Compared with normoxia, hyperoxia during cardiac surgery does not impact in-hospital or 30-day mortality but is associated with worsening physiological and biochemical parameters.

Study context

Population
Patients undergoing cardiac surgery with CPB or off-pump procedures
Participants
2,001 patients · 19 randomized clinical trials (RCTs)
Comparison
Intraoperative hyperoxia vs normoxia
  • Hyperoxian = 982
Outcome
In-hospital and 30-day mortality
Methodological detailstrial sequential analysis, subgroup analysis by oxygenation definition (PaO₂-based v FiO₂-based)
  • Trial sequential analysis
  • Subgroup analysis by oxygenation definition (PaO₂-based v FiO₂-based)

Pooled result

As reported in the abstract

In-hospital mortality not different between hyperoxia and normoxia: 9/798 [1.1%] v 10/799 [1.3%]

RR 0.84, 95% CI 0.36 to 1.94

p = 0.684

30-day mortality not different between hyperoxia and normoxia: 1/282 [0.4%] v 4/280 [1.4%]

RR 0.41, 95% CI 0.08 to 2.28

p = 0.311

Further pooled results

Postoperative PaO2/FiO2 ratio

Higher in the normoxia group
MD −31.49, 95% CI −47.13 to −15.85, p < 0.01

Creatine kinase-MB

Higher in the hyperoxia group
SMD 1.65, 95% CI 0.12 to 3.18, p = 0.03

Malondialdehyde

Higher in the hyperoxia group
SMD 3.77, 95% CI 2.99 to 4.55, p < 0.01

Original publication

Impact of Intraoperative Hyperoxia Versus Normoxia on Mortality and Organ Injury in Cardiac Surgery: A Systematic Review and Meta-analysis of Randomized Clinical Trials. J Cardiothorac Vasc Anesth. Published 22 September 2025. doi:10.1053/j.jvca.2025.09.042

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.